XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 1,891,000 $ 235,000
Trade accounts receivable, net 2,489,000 829,000
Other receivables 62,000 55,000
Inventory, net 1,074,000 1,500,000
Prepaid expenses and other current assets 155,000 104,000
Total current assets 5,671,000 2,723,000
Property, plant and equipment, net of depreciation 697,000 333,000
Intangible assets, net of amortization 125,000 178,000
Other non-current assets 302,000 84,000
Total assets 6,795,000 3,318,000
Current liabilities:    
Line of credit 1,736,000 609,000
Accounts payable 1,729,000 1,200,000
Disputed co-manufacturer accounts payable (Note 4) 499,000 499,000
Accrued expenses 222,000 142,000
Accrued payroll and employee related expenses 92,000 67,000
Financing agreements - current 266,000 99,000
Total current liabilities 4,544,000 2,616,000
Financing agreements 330,000 124,000
Total liabilities 4,874,000 2,740,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.000001 par value, 400,000 shares authorized, none issued or outstanding
Common stock, $0.000001 par value; 23,000,000 shares authorized; and 15,940,261 and 14,746,172 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
Additional paid in capital 67,473,000 64,199,000
Accumulated deficit (65,552,000) (63,621,000)
Total stockholders’ equity 1,921,000 578,000
Total liabilities and stockholders’ equity $ 6,795,000 $ 3,318,000